Volatile organic compound profiling to explore primary graft dysfunction after lung transplantation.

Area of Science:

• Pulmonary Medicine
• Analytical Chemistry
• Transplant Immunology

Background:

• Primary graft dysfunction (PGD) significantly impacts lung transplant outcomes.
• Understanding the molecular mechanisms of PGD is crucial for improving patient survival.
• Current methods for PGD assessment may lack early predictive capabilities.

Purpose of the Study:

• To investigate the association between pulmonary volatile organic compound (VOC) profiles and PGD severity.
• To explore the potential of VOCs as biomarkers for predicting PGD.
• To correlate VOC signatures with postoperative outcomes in lung transplant recipients.

Main Methods:

• Collected bronchoalveolar lavage fluid (BALF) and bronchial aspirate samples from 35 lung transplant patients.
• Utilized solid-phase microextraction (SPME) for VOC extraction.
• Analyzed VOCs using comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry (GCxGC-TOFMS).
• Applied support vector machine (SVM) algorithms for data analysis and classification.

Main Results:

• A panel of 20 VOCs from early post-transplant samples differentiated severe PGD from low PGD with high accuracy (AUROC 0.90, accuracy 0.83).
• The VOC model showed moderate effectiveness for later time points (AUROC 0.80).
• Severe PGD samples were characterized by elevated levels of alkylated hydrocarbons, linear hydrocarbons, and aldehydes.

Conclusions:

• Pulmonary VOC profiles show promise as non-invasive biomarkers for early PGD detection.
• Specific VOC signatures, including hydrocarbons and aldehydes, are associated with severe PGD.
• Further large-scale studies are warranted to validate these findings and explore breath analysis for clinical application.